Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Pancreatic Neoplasms 1 Gastric Adenocarcinoma 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Arthritis, Rheumatoid 1

Interventions

Oxaliplatin 53 Cisplatin 52 Fluorouracil 50 Capecitabine 48 pembrolizumab 38 Leucovorin 31 Docetaxel 26 Trastuzumab 23 Paclitaxel 20 Irinotecan 20 Ramucirumab 12 Bevacizumab 12 Cetuximab 9 Radiotherapy 8 Surgical Procedures, Operative 7 S 1 (combination) 7 Nivolumab 7 Epirubicin 7 Carboplatin 6 olaparib 5 Platinum 5 Everolimus 5 Sunitinib 4 Mitomycin 4 trastuzumab deruxtecan 3 lenvatinib 3 epacadostat 3 bemarituzumab 3 apatinib 3 Saline Solution 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Stomach Neoplasms × andecaliximab × Clear all

NCT02545504 2020-05-26

GAMMA-1

Gilead Sciences

Phase 3 Completed

432 enrolled 19 charts

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡